Xuedong Chi

Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

Ajay K. Gopal, Robert Chen, Scott E. Smith et al. · Blood · 2014 · 222 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double‐blind, placebo‐controlled, randomized, proof‐of‐concept study

Clarissa E. Vergunst, Daniëlle M. Gerlag, Lisa Von Moltke et al. · Arthritis & Rheumatism · 2009 · 81 citations

Medicine, Pharmacology, Pharmacotherapy +13

Physiological levels of<i>β</i>-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production

J. M. Price, Xuedong Chi, Gary Hellermann et al. · Neurological Research · 2001 · 80 citations

Life Sciences, Neurobiology, Neuroscience +17

<b> <i>p53</i> </b> Polymorphism and Age of Onset of Hereditary Nonpolyposis Colorectal Cancer in a Caucasian Population

J. Shawn Jones, Xuedong Chi, Xiangjun Gu et al. · Clinical Cancer Research · 2004 · 74 citations · Full text

Life Sciences, Genetics, Oncology +17

Prevention of cultured rat stellate cell transformation and endothelin‐B receptor upregulation by retinoic acid

Xuedong Chi, Kristin Anselmi, Simon C. Watkins et al. · British Journal of Pharmacology · 2003 · 25 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17